PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model

Thumbnail Image

Files

2022_intjpharm_garcia_pet.pdf (3.63 MB)
Identifiers
URI: http://hdl.handle.net/10347/29388
E-ISSN: 0378-5173
DOI: 10.1016/j.ijpharm.2022.122261

Publication date

2022

Authors

Advisors

Tutors

Editors

Journal Title

Journal ISSN

Volume Title

Publisher

Elsevier
Metrics
Google Scholar
lacobus
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Description

Keywords

Adalimumab| Anti-TNFα| Pharmacokinetics| Molecular imaging| Positron| Emission Tomography| Endotoxin-induced uveitis

Bibliographic citation

International Journal of Pharmaceutics 627 (2022) 122261

Relation

Has part

Has version

Is based on

Is part of

Is referenced by

Is version of

Requires

Sponsors

X. García-Otero is grateful to the IDIS (Health Research Institute of Santiago de Compostela) for financing his predoctoral research fellowship. C. Mondelo-García, E. Bandín-Vilar and A. Fernández-Ferreiro are grateful to the Carlos III Health Institute for financing their personnel contracts: JR20/00026, CM20/00135 and JR18/00014.

Rights

Attribution-NonCommercial-NoDerivatives 4.0 International

Collections

Farmacoloxía, Farmacia e Tecnoloxía Farmacéutica
Estatística, Análise Matemática e Optimización
Zooloxía, Xenética e Antropoloxía Física